Klaus Rose

11PUBLICATIONS
6CO-AUTHORS
Molecular targetsPharmacogenomicsClinical pharmacology and therapeuticsAdolescent healthPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 04, 2025
Melanoma and pediatric drug development: clinical progress vs. regulatory activism in minors - a narrative review.

Earl B Ettienne, Jane M Grant-Kels, Pasquale Striano

|Sep 13, 2024
Pharmacogenomics and pediatric drug development: science and political power. A narrative review.

Earl B Ettienne, Jane M Grant-Kels, Pasquale Striano

|Aug 25, 2022
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overview.

Gianluca D'Onofrio, Antonella Riva, Elisabetta Amadori

|Feb 25, 2022
Neurology's vital role in preventing unnecessary and potentially harmful pediatric studies.

Klaus Rose, Earl B Ettienne, Jane M Grant-Kels

|Dec 12, 2018
The Meanings of "Pediatric Drug Development".

Klaus Rose, Jane M Grant-Kels

|Sep 11, 2017
Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?

Klaus Rose, Philip D Walson

Pageof 2

Frequent Collaborators

4 joint publications

Pasquale Striano

2 joint publications

Earl B Ettienne

2 joint publications

Emilio Russo

1 joint publications

Simona Lattanzi